Publications by authors named "Matthew A Cavender"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

354

Total Likes

19

Extended Reach

8,944

Social Features

5
S
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.
Benjamin M Scirica, Deepak L Bhatt, Eugene Braunwald, P Gabriel Steg, Jaime Davidson, Boaz Hirshberg, Peter Ohman, Robert Frederich, Stephen D Wiviott, Elaine B Hoffman

N Engl J Med· October 2013

Videos about Article: user user

2 21 3 9 24

View All Article and Social Media Activity
P
Public Reporting and Risk Aversion: Robust Risk Adjustment Is the Cure.
Rajiv Patel, David Shahian, Matthew A Cavender

Circ Cardiovasc Interv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of patients prescribed SGLT-2i and/or GLP-1RA among cardiology clinics in the US: insights from the COORDINATE-diabetes trial.
Adam J Nelson, Lisa A Kaltenbach, Hussein R Al-Khalidi, Monica Leyva, Laura Webb, Matthew A Cavender

Am J Prev Cardiol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes.
Darren K McGuire, Nikolaus Marx, Sharon L Mulvagh, John E Deanfield, Silvio E Inzucchi, Matthew A Cavender

N Engl J Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discontinuation of SGLT-2i and GLP-1RA among persons with Type 2 diabetes and atherosclerotic cardiovascular disease treated in US cardiology clinics.
Adam J Nelson, Lisa A Kaltenbach, Darren K McGuire, Monica Levya, Hussein R Al-Khalidi, Matthew A Cavender

Am Heart J· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The IMproving treatment decisions for Patients with AortiC stenosis Through Shared Decision Making (IMPACT SDM) Study: study protocol for a cluster randomized stepped wedge trial.
Karen Sepucha, Sammy Elmariah, K D Valentine, Matthew A Cavender, Yuchiao Chang

Trials· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How Can We Increase the Utilization of Evidence-Based Medication After Myocardial Infarction?
Matthew A Cavender, Sidney C Smith

JAMA Netw Open· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing Outcomes in ST-Segment Elevation Myocardial Infarction: Is Prolonged Infusion of Bivalirudin Part of the Solution?
Matthew A Cavender

J Am Coll Cardiol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perspectives in Managing Kidney Disease and Atherosclerotic Cardiovascular Disease.
Tarlan Namvar, Matthew A Cavender, Eden Miller, Sherif Mehanna, Reese Ochsner

Cardiorenal Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of an Intervention to Improve Evidence-Based Care for People With Diabetes and Cardiovascular Disease Across Sex, Race, and Ethnicity Subgroups: Insights From the COORDINATE-Diabetes Trial.
Manasi Tannu, Lisa Kaltenbach, Neha J Pagidipati, Darren K McGuire, Vanita R Aroda, Matthew A Cavender

Circulation· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-weekly semaglutide reduces the risk of cardiovascular events in people with type 2 diabetes and polyvascular disease: A post hoc analysis.
Ofer Kobo, Matthew A Cavender, Thomas Jon Jensen, Anja Birk Kuhlman, Søren Rasmussen

Diabetes Obes Metab· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deferring PCI Based on IVUS Assessment: On Par With FFR or FLAVOUR of the Week?
Max W Maffey, Matthew A Cavender, Rodrigo Bagur

Circ Cardiovasc Interv· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Another Step Forward in Our Ability to Predict Percutaneous Coronary Intervention Outcomes.
Araba Ofosu-Somuah, Matthew A Cavender, George A Stouffer

Am J Cardiol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiorenal care coordination: holistic patient care opportunities in the primary care setting for patients with chronic kidney disease and atherosclerotic cardiovascular disease.
Eden Miller, Dominic Raj, Matthew A Cavender, Sherif Mehanna, Tarlan Namvar

Postgrad Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lower risk of cardiovascular events and death associated with initiation of sodium-glucose cotransporter-2 inhibitors versus sulphonylureas: Analysis from the CVD-REAL 2 study.
Su-Yen Goh, Mikhail N Kosiborod, Carolyn S P Lam, Matthew A Cavender, Shun Kohsaka

Diabetes Obes Metab· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex differences in device-measured physical activity after transcatheter aortic valve replacement.
Anthony J Mazzella, Anil K Gehi, Ryan Searcy, John P Vavalle, Matthew A Cavender

J Invasive Cardiol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coordinated Care to Optimize Cardiovascular Preventive Therapies in Type 2 Diabetes: A Randomized Clinical Trial.
Neha J Pagidipati, Adam J Nelson, Lisa A Kaltenbach, Monica Leyva, Darren K McGuire, Matthew A Cavender

JAMA· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients and Their Physician's Perspectives About Oral Anticoagulation in Patients With Atrial Fibrillation Not Receiving an Anticoagulant.
Christopher P Cannon, Joseph M Kim, Jane J Lee, Julie Sutherland, Ravinder Bachireddy, Matthew A Cavender

JAMA Netw Open· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology and Outcomes of Aortic Stenosis in Acute Decompensated Heart Failure: The ARIC Study.
Krishan Sivaraj, Sameer Arora, Michael Hendrickson, Trisha Slehria, Patricia P Chang, Matthew A Cavender

Circ Heart Fail· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coordinating Cardiology clinics randomized trial of interventions to improve outcomes (COORDINATE) - Diabetes: rationale and design.
Adam J Nelson, Neha J Pagidipati, Michelle D Kelsey, Maddalena Ardissino, Vanita R Aroda, Matthew A Cavender

Am Heart J· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in Percutaneous Balloon Mitral Valvuloplasty Complications for Mitral Stenosis in the United States (the National Inpatient Sample [2008 to 2018]).
Trisha Slehria, Michael J Hendrickson, Krishan Sivaraj, Sameer Arora, Thomas G Caranasos, Matthew A Cavender

Am J Cardiol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response by Cavender et al to Letter Regarding Article, "Ischemic Events Occur Early in Patients Undergoing Percutaneous Coronary Intervention and Are Reduced With Cangrelor: Findings From CHAMPION PHOENIX".
Matthew A Cavender, Robert A Harrington, Deepak L Bhatt

Circ Cardiovasc Interv· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preventing Left Ventricular Thrombus Formation: Another Reason to Use Very Low-Dose Rivaroxaban?
Matthew A Cavender, Grayson C Eubanks

JACC Cardiovasc Interv· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Lipid-, Blood Pressure-, and Glucose-Lowering Pharmacotherapy in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease.
Adam J Nelson, Emily C O'Brien, Lisa A Kaltenbach, Jennifer B Green, Renato D Lopes, Matthew A Cavender

JAMA Netw Open· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ischemic Events Occur Early in Patients Undergoing Percutaneous Coronary Intervention and Are Reduced With Cangrelor: Findings From CHAMPION PHOENIX.
Matthew A Cavender, Robert A Harrington, Gregg W Stone, Ph Gabriel Steg, C Michael Gibson

Circ Cardiovasc Interv· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Primary Care Clinicians in the Management of Patients With Type 2 Diabetes and Cardiorenal Diseases.
Pamela R Kushner, Matthew A Cavender, Christian W Mende

Clin Diabetes· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis